Diseases, Conditions, Syndromes

Researchers develop software to predict diseases

IntelliGenes, a first-of-its-kind software created at Rutgers Health, combines artificial intelligence (AI) and machine-learning approaches to measure the significance of specific genomic biomarkers to help predict diseases ...

Oncology & Cancer

Targeting annexin-A1 can halt cancer cell growth, study finds

A new study published in Oncogene highlights the effectiveness of MDX-124, the first therapeutic drug to target annexin-A1, a protein that is overexpressed in several cancer types and promotes tumor progression.

Health

WHO weighs up AI risks and benefits for health care

Generative artificial intelligence could transform health care through things like drug development and quicker diagnoses, but the World Health Organization warned Thursday of the potential pitfalls in rushing to embrace ...

page 7 from 40